Hc1 + Accumen Launches Next Generation Of Clinical Excellence Solutions

hc1’s patented technology has generated over $250 million in savings across 300 health systems

INDIANAPOLIS--(BUSINESS WIRE)--hc1 + Accumen introduced its next-generation Clinical Excellence solutions today, a comprehensive suite of software and services that improve patient health through personalized diagnostic lab testing and optimized blood transfusion management. By translating lab data into actionable insights for clinicians, hc1 Clinical Excellence tells the story of an individual’s health across the patient care journey to predict patient needs, minimize avoidable illness, and eliminate unnecessary costs.

hc1's clinician-built solutions use patented machine learning and AI-driven technology to analyze tens of millions of critical lab values and generate in-depth, personalized insights for every patient's care journey. According to the Centers for Disease Control and Prevention, lab tests are crucial for monitoring patient health and inform 70% of healthcare decisions.

“When analyzed holistically, lab test results hold incredible promise to optimize an individual’s health journey from birth to death,” said hc1 CEO, Founder, and Chairman Bradley Bostic. “As the leader in transforming lab data into actionable insights, hc1 is the ideal partner for CEOs to tap into the strategic opportunity for the lab to improve patient health while increasing system-wide profits.”

hc1’s Clinical Excellence solutions were developed to improve a patient’s quality of life, avoid needless procedures, and support sustainable clinical advancements by using real-time analytics to eliminate outdated tests, identify high risk patients through lab results analysis, and reduce unnecessary transfusions by up to 30%, promoting safer care and a stable blood supply.

Assistant Professor of Anesthesiology and Perioperative Medicine at Oregon Health & Science University (OHSU) School of Medicine Dr. Jeffrey Wagner shared, "hc1 + Accumen’s technology pays for itself. It helps us to see more patients with more information better. Likewise, their people have been extremely helpful in working with us to establish this program at OHSU. They anticipate, are responsive, and have become professional colleagues and partners.”

Dr. Wagner added, “The idea is to be brave, implement, and reap the benefits for your patients and hospital system. To that end, hc1 + Accumen is essential for any hospital who wants to move that one step forward, and then two steps forward, to address all of its patient blood management interests."

In today's fast-changing healthcare world, embracing new solutions is crucial to staying ahead. Visit here to discover how hc1's next-generation Clinical Excellence solutions improve the patient journey and ​​contribute to significant savings in the health system.

About hc1 + Accumen

The new hc1 + Accumen, together, unlock the vast potential of actionable lab data to improve patient care and boost the financial performance of the healthcare system. By partnering with hc1 + Accumen, health systems gain profitable new growth and improve patient outcomes. Our solutions use advanced data management, analytics, and workflow automation powered by AI to uncover actionable insights and hidden risk signals, delivering innovation, operational and clinical excellence, and revenue growth across the entire care continuum. With over a decade of experience and thousands of health systems and labs leveraging our technology and consultative services to care for nearly 100 million patients, we provide the expertise needed to unlock the strategic value of your lab data, improving patient outcomes and boosting financial performance. Healthcare Progress Starts Here.™ With hc1 + Accumen. Learn more about our proven approach at www.hc1.com.

Contacts

For media inquiries, please contact:
Alexis Feinberg
Vice President, ICR Healthcare
Alexis.feinberg@icrhealthcare.com